Les maladies inflammatoires chroniques de l’intestin (MICI) représentent un problème de santé publique majeur touchant de jeunes patients. Aux récidives inflammatoires, à la mauvaise qualité de vie et à l’espérance de vie réduite des patients viennent s’ajouter la durée, l’efficacité parfois limitée et le coût des traitements actuellement proposés. La recherche de nouvelles stratégies permettant de prévenir les récidives inflammatoires est primordiale. Ainsi, le rôle du S-nitrosoglutathion (GSNO, donneur et forme de stockage naturelle de NO) dans le maintien de l’intégrité de la barrière intestinale est étudié dans cette thèse, en décrivant : i) l’effet concentration-dépendante du GSNO sur la perméabilité intestinale (modèle de chambre de Ussing, expression des protéines de jonctions cellulaires…), ii) des formulations innovantes de GSNO (nanoparticules composites) à base de nanoparticules d’Eudragit®RL, elles-mêmes encapsulées dans une matrice polymérique à base d’alginate. Différents procédés de formulation ont été testés. Une caractérisation physicochimique des objets développés et des études de perméabilité sur des modèles cellulaires (Caco-2) ont conduit à l’obtention de trois formulations, adaptées à la voie orale et permettant de délivrer de façon prolongée le GSNO. Cependant, la prise en charge du GSNO libre ou formulé, l’identification des cibles du NO au niveau intestinal, mais aussi les doses et durées du traitement in vivo restent encore à définir avant de proposer ce donneur de NO comme candidat pour un traitement préventif des MICI / Inflammatory bowel diseases (IBD) (Crohn’s disease, ulcerative colitis…), are disabling pathologies affecting young patients and presenting the particularity that most of the current agents act by down regulating chronic inflammation in the intestine mucosa and cannot cure the disease. As the pivotal role of S-nitrosoglutathione (GSNO) in preventing intestinal inflammation and gut barrier failure has been clearly pointed out, therapies based on pharmaceutical technology to limit chronic inflammation and prevent relapses of barrier failure by an optimized dosage form of GSNO appears as an interesting challenge. The objective of this project relies on i) studying GSNO concentration/response functions in intestine by using Ussing chamber ex vivo model and following protein cell junction expression, ii) developing polymer nanocomposite particles encapsulating GSNO and adapted to the oral route, with GSNO protection, controlled delivery and local effect in intestine as major requirements. GSNO loaded polymeric (Eudragit® RL) nanoparticles were included in polymer matrix based on alginate; different processes were tested and particles were characterized: high GSNO loading, GSNO sustained release and local retention for 4 h in cellulo study (Caco-2) were obtained. Thus, therapies based on GSNO administration should represent a novel strategy to limit chronic inflammation and prevent relapses of barrier failure in IBD patients

O estudo da adição de dopantes pentavalentes é uma das principais linhas de pesquisas em eletrocerâmicas para varistores de TiO2. Diversos autores têm buscado entender os efeitos destes dopantes nas propriedades elétricas e microestruturais destas cerâmicas eletrônicas. Este trabalho apresenta um estudo do comportamento eletrônico do TiO2 frente a adição de Ta2O5 em concentrações maiores das já estudas, buscando obter varistores binários para aplicação em baixa tensão. Sistemas a base de TiO2 dopados com Ta2O5 foram preparados por mistura convencional de óxidos e conformados na forma de disco. A microestrutura dos compactos contendo 0,5, 1,0, 1,5 e 2,0% em mol de Ta2O5, sinterizados a uma taxa de aquecimento de 5°C/min. em 1300°, 1350° e 1400°C por 1 hora, foram analisadas, apresentando a evolução da microestrutura frente a temperatura de sinterização. Os valores da densidade das amostras foram obtidos através do método de Arquimedes, demonstrando a contribuição do Ta2O5 na densificação dos sistemas, e através de difração de raios X, foi possível determinar a fase presente nestas cerâmicas. Para avaliar as propriedades elétricas, realizou-se medidas de tensão-corrente (CC) em temperatura ambiente e em função da temperatura, obtendo coeficiente não-linear, altura e largura da barreira de potencial. Utilizando a espectroscopia de impedância avaliou-se o comportamento dos sistemas, medindo a contribuição do grão e do contorno de grão, calculando a energia de ativação. As medidas Mott-Schottky foram obtidas, possibilitando estimar a concentração de doadores e densidade de estados eletrônico. Na temperatura mais elevada de sinterização, 1400°C, melhorou-se as características varistoras, ocorrendo aumento da densificação e redução do campo elétrico de ruptura, apresentando com um nível ideal do dopante, 1% em mol de Ta2O5, varistores com coeficiente não-linear de 5,3 e baixo campo elétrico de ruptura de 38,4 V/cm. / The study of additional pentavalent dopants is one of the main research lines in electroceramics for TiO2 varistors. Several authors have sought to understand the effect this dopants in eletrical and microstructural properties of these electronic ceramics. This work presents a study of the electronic behavior of TiO2 versus the addition of Ta2O5 in higher concentrations of those already studied, in order to obtain binary varistors for low voltage application. TiO2 based systems doped with Ta2O5 were prepared by the conventional mixture of oxides and shaped in the disk form. The microstructure of the composites containing 0.5, 1.0, 1.5 and 2.0 mol% of Ta2O5, sintered at a heating rate of 5°C/min. at temperatures of 1300°, 1350° and 1400°C for 1 hour were analyzed, showing a development of the microstructure against a sintering temperature. The density values of the samples were obtained by the Archimedes method, demonstrating a contribution of Ta2O5 in the densification of the systems; and, by means of X-ray diffraction, it was possible to determine a phase present in these ceramics. In order to evaluate electrical properties, voltage-current (DC) measurements were performed at room temperature and changing the temperature, obtaining nonlinear coefficient, height and width of the potential barrier. Using impedance spectroscopy, evaluate the behavior of the systems by measuring a contribution of the grain and the grain boundary, calculating an activation energy. As Mott-Schottky measurements were obtained, making it possible to estimate a concentration of donors and density of electronic states. At the higher sintering temperature, 1400°C, varistor characteristics were improved, increasing densification and reduction of the break down electric field, showing with the ideal level of dopant, 1.0 mol% of Ta2O5, varistors with nonlinear coefficient of 5.3 and low break down electric field of 38.4 V/cm.

Cerebral small vessel disease (SVD) is a common cause of strokes and dementia. The pathogenesis of SVD is poorly understood, but imaging and biochemical investigations suggest that subtle blood-brain barrier (BBB) leakage may contribute to tissue damage. The most widely-used imaging method for assessing BBB integrity and other microvascular properties is dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI). DCE-MRI has primarily been applied in situations where contrast uptake in tissue is typically large and rapid (e.g. neuro-oncology); the optimal approach for quantifying BBB integrity in diseases where the BBB remains largely intact and the reliability of resulting measurements is unclear. The main purpose of this thesis was to assess and improve the reliability of quantitative assessment of subtle BBB disruption, in order to illuminate its potential role in cerebral SVD. Firstly, a systematic literature review was performed in order to provide an overview of DCE-MRI methods in the brain. This review found large variations in MRI procedures and data analysis methods, resulting in widely varying estimates of tracer kinetic parameters. Secondly, this thesis focused on the analysis of DCE-MRI data acquired in an on-site clinical study of mild stroke patients. After performing basic DCE-MRI processing (e.g. selection of a vascular input function), this work aimed to determine the tracer kinetic modelling approach most suitable for assessing subtle BBB disruption in this cohort. Using data-driven model selection and computer simulations, the Patlak model was found to provide accurate estimates of blood plasma volume and low-level BBB leakage. Thirdly, this thesis aimed to investigate two potential pitfalls in the quantification of subtle BBB disruption. Contrast-free measurements in healthy volunteers revealed that a signal drift of approximately 0.1 %/min occurs during the DCE-MRI acquisition; computer simulations showed that this drift introduces significant systematic errors when estimating low-level tracer kinetic parameters. Furthermore, tracer kinetic analysis was performed in an external patient cohort in order to investigate the inter-study comparability of DCE-MRI measurements. Due to the nature of the acquisition protocol it proved difficult to obtain reliable estimates of BBB leakage, highlighting the importance of study design. Lastly, this thesis examined the relationship between quantitative MRI parameters and clinical measurements in cerebral SVD, with a focus on the estimates of blood volume and BBB leakage obtained in the internal SVD patient cohort. This work did not provide evidence that BBB leakage in normal-appearing tissue increases with SVD burden or predicts disease progression; however, increased BBB leakage was found in white matter hyperintensities. Furthermore, this work raises the possibility of a role for blood plasma volume and dietary salt intake in cerebral SVD. The work described in this thesis has demonstrated that it is possible to estimate subtle BBB disruption using DCE-MRI, provided that the measurement and data analysis strategies are carefully optimised. However, absolute values of tracer kinetic parameters should be interpreted with caution, particularly when making comparisons between studies, and sources of error and their influence should be estimated where possible. The exact roles of BBB breakdown and other microvascular changes in SVD pathology remain to be defined; however, the work presented in this thesis contributes further insights and, together with technical advances, will facilitate improved study design in the future.

A sonotrombólise pela combinação de ultrassom (US) e microbolhas com medicamento trombolítico tem indicado grande eficácia na quebra de coágulos in vitro, devido a efeitos de cavitação. Contudo, estudos in vivo sobre drug delivery demonstram que a cavitação de microbolhas é também capaz de abrir local e transientemente a barreira hematoencefálica (BHE) - estrutura de permeabilidade seletiva que protege o Sistema Nervoso Central. Um estudo clínico sobre sonotrombólise foi interrompido precocemente devido a evolução de casos de Acidente Vascular Cerebral isquêmicos para hemorrágicos associados a danos na BHE e formação de ondas estacionárias. Nesta tese, foram realizados estudos in vitro e in vivo sobre técnicas de US multifrequencial para trombólise. Além disso, verificou-se os limiares para a abertura da BHE e efeitos de neuromodulação ambos causados pelo ultrassom transcraniano. Foi demonstrado que o duplo feixe de US e a variação temporal de frequências (excitação codificada) são capazes de reduzir a formação de ondas estacionárias e gerar regiões focais mais confinadas do que feixes focalizados monofrequenciais. O duplo feixe foi incapaz de gerar ondas de baixa frequência para trombólise (menor ou igual a 1 Pa para feixes primários de 1,58 MPa). Exames histológicos e por imagens de ressonância magnética mostraram que a cavitação de microbolhas pode causar danos ao tecido cerebral para níveis de pressão de mesma ordem necessários para se observar efeito trombolítico. Além disso, foi observado que o US é capaz de disparar atividade neuronal causando respostas motoras e indícios de respostas associadas a modulação de atividades cognitivas. A focalização de feixes por excitação multifrequencial é um grande avanço para sonotrombólise. Contudo, a potencialização do efeito trombolítico do US por cavitação e medicamento é limitada devido a danos a BHE e critérios de exclusão do medicamento. / Sonothrombolysis by combining ultrasound (US) and microbubbles with thrombolytic drugs has been demonstrated capable of breaking blood clots in in vitro studies, due to cavitation effects. However, in vivo drug delivery studies have demonstrated that cavitation of microbubbles is also capable of opening locally and transiently the blood-brain barrier (BBB) - structure with selective permeability that protects the Central Nervous System. A sonothrombolysis clinical study was interrupted prematurely because of the occurrence of intracerebral hemorrhages after treatment associated with damages in the BBB and standing waves formation. In this dissertation, in vitro and in vivo studies evaluated techniques of multifrequency US for thrombolysis. Furthermore, the ultrasound pressure threshold to obtain the BBB opening and neuromodulation effects were explored during transcranial insonation. It has been demonstrated that the double US beam and the time variation of frequencies (coded excitation) are capable of reducing standing wave formation and generating more confined focus zones than monofrequency focused beams. The double US beam was not capable of generating low frequency waves for thrombolysis (less than or equal to 1 Pa obtained from primary beams with 1.58 MPa). Histological exams and magnetic resonance images demonstrated that microbubbles cavitation can damage the brain tissue with acoustic pressures of the same level necessary to observe thrombolytic effects. Furthermore, it was observed motor responses and other responses associated with cognitive activity triggered by US. The capability of multifrequency excitation in focusing US beams is an important advance for sonothrombolysis. However, the enhancement of fibrinolytic effect of US by microbubbles cavitation and with thrombolytic drugs is limited by associated damages to the BBB and by exclusion criteria for the use of the thrombolytic drugs.

A barreira placentária é constituída por duas camadas de células sinciciais, uma camada de células trofoblásticas gigantes e o endotélio fetal. Apesar da importância das camadas sinciciais no transporte molecular entre mãe e feto, o exato mecanismo de formação dessa barreira não está completamente elucidado em camundongos. Em humanos, estudos sugerem que a formação do sinciciotrofoblasto ocorre por um processo de fusão celular dependente de Caspase- 8, uma proteína iniciadora da cascata de apoptose. Desta forma, este estudo teve como proposta analisar o processo de formação das camadas sinciciais do labirinto em placentas de camundongos e o possível envolvimento da caspase-8 neste processo. Sítios de implantação foram coletados de camundongos fêmeas nos dias 8,5 a 11,5 de gestação e caracterizados morfologicamente através de marcadores de células precursoras sinciciais (EpCAM) e de células sinciciais maduras (Slc16A3) por meio de reações imunohitoquímicas. A expressão gênica dos marcadores diferenciais de células sinciciais também foi analisada por RT-PCR na região labiríntica dissecada nos diferentes dias de gestação. A expressão de Caspase-8 total e clivada também foi avaliada por Western blot e a relação entre a presença de Caspase-8 clivada e a indução de apoptose, avaliada por TUNEL e pela imunolocalização da Citoqueratina 18 clivada. Tambem foram realizadas análises com células labirínticas cultivadas, isoladas nos dias 8,5 a 10,5 de gestação. As células cultivadas foram caracterizadas morfologicamente e avaliadas quanto a expressão gênica de marcadores sinciciais e proteica de Caspase-8. Nossos resultados mostraram que os primeiros sinais morfológicos de formação da barreira placentária ocorream no dia 9,5 de gestação. O marcador EpCAM foi encontrado na base da placenta nos dias 8,5 e 9,5. No dia 11,5 de gestação, o labirinto já se encontra estruturado e funcional, o que foi indicado pela expressão de Slc16A3, nos dias 10,5 e 11,5 de gestação. A expressão gênica dos fatores de transcrição associados ao desenvolvimento das camadas sinciciais mostraram expressões crescentes ao longo do período estudado. Caspase-8 total e clivada mostrou intensa expressão no dia 9,5 de gestação, e aparentemente não estava associada à morte celular por apoptose, uma vez que não se detectou reatividade pela reação de TUNEL ou imunomarcação de Citoqueratina 18 clivada nas células labirínticas em formação em nenhum dos dias estudados. Células labirínticas obtidas aos 9,5 dias de gestação e cultivadas formaram ninhos celulares ao longo das 48 horas de cultura, com indícios morfológicos de sincicialização. A imunolocalização do marcador de células progenitoras do labirinto, EpCAM foi mais intensa nas culturas de 6 horas e se limitou a áreas ao redor dos ninhos celulares após 48 horas. Inversamente, a imunolocalização do transportador sincicial Slc16A3 não foi observada após 6 horas de cultura, mas foi bastante intensa no centro dos ninhos celulares após 48 horas. As culturas de labirinto de 9,5 das de gestação, também mostraram aumento de expressão das Sincitinas A e B ao longo do tempo de cultivo. A análise da expressão proteica de Caspase-8 mostrou expressão mais alta após 6 horas de cultivo do que a observada nos demais tempos experimentais. Por outro lado, a forma ativa (clivada) da caspase aumentou gradativamente após 24 e 48 horas de cultivo. Culturas submetidas ao tratamento com o inibidor farmacológico de Caspase-8 z-IEDT-fmk, mostraram perfis morfológicos alterados com redução da formação dos ninhos celulares e diminuição da reatividade ao Slc16A3. A expressão dos marcadores de diferenciação Sincitina A e B também foi significativamente diminuída (p<0.05) nestes experimentos em que a inibição da Caspase-8 clivada foi comprovada por Western blot. Estes achados mostraram a expressão de Caspase- 8, principalmente no dia 9,5 de gestação, nas células trofoblásticas labirínticas da placenta de camundongos e sugerem sua participação na formação das camadas sinciciais do labirinto. / Two layers of syncytial cells, a layer of trophoblastic giant cells and the fetal endothelium form the placental barrier. Despite the importance of the syncytial layers in molecular transport between mother and fetus, its exact developmental mechanism is still not completely elucidated in rodents. In humans, studies suggest that the formation of the syncytiotrophoblast occurs through a cell fusion process dependent on Caspase-8, an apoptosis cascade-initiating protein. In this way, this study had the proposal to analyze the process of formation of the syncytial layers of the labyrinth in placentas of mice and the possible involvement of Caspase-8 in this process. Implantation sites were collected from female mice on days 8.5 to 11.5 of gestation and morphologically characterized by the labyrinthine precursor cell marker EpCAM, and the mature syncytial cell marker - Slc16A3, through immunohistochemical reactions. The gene expression of the differential markers of syncytial cells was analyzed by RT-PCR in the labyrinthine region dissected on the different days of gestation. Total and cleaved Caspase-8 expression was also evaluated by Western blot and the relationship between the presence of cleaved Caspase-8 and the induction of apoptosis as assessed by TUNEL and the immunolocalization of the cleaved Cytokeratin 18. Analyzes were also performed with cultured labyrinth cells, isolated on days 8.5 to 10.5 of gestation. The cultured cells were characterized morphologically and evaluated for the gene expression of syncytial markers and Caspase-8 protein. Our results showed that the first morphological signs of placental barrier formation occurred on day 9.5 of gestation. The EpCAM marker was found at the base of the placenta on days 8.5 and 9.5. At day 11.5 of gestation, the labyrinth is already structured and functional, which was indicated by the expression of Slc16A3, on days 10.5 and 11.5 of gestation. The gene expression of the transcription factors associated with the development of the syncytial layers showed increased throughout the studied period. Total and cleaved Caspase-8 showed intense expression at day 9.5 of gestation, and apparently was not associated with cell death by apoptosis, since no reactivity was detected by the TUNEL reaction or cleaved Cytokeratin 18 immunolabeling in the labyrinthine zone. Labyrinthine cells obtained at 9.5 days of gestation formed nests during the 48 hours of culture, with morphological signs of syncytialization. Immunolocalization of the progenitor cell marker EpCAM was more intense in the 6-hour cultures and was limited to areas around the cell nests after 48 hours. Conversely, immunolocalization of the syncytial transporter Slc16A3 was not observed after 6 hours of culture but was quite intense at the center of the cell nests after 48 hours. Labyrinthine cell cultures of 9.5 gestation days also showed increased expression of A and B syncytins throughout the culture time. Analysis of the protein expression of Caspase- 8 showed higher expression after 6 hours of culture than that observed in the other experimental times. On the other hand, the active (cleaved) form of Caspase gradually increased after 24 and 48 hours of culture. Cultures submitted to the pharmacological inhibitor of Caspase-8 - z-IEDT-fmk showed altered morphological 18 profiles with reduction of cell nests formation and a decrease of reactivity to Slc16A3. The expression of the differentiation markers A and B Syncytins was also significantly decreased (p <0.05) in the experiments, in which the inhibition of the cleaved Caspase-8 was confirmed by Western blot. These findings show the expression of Caspase-8, mainly on day 9.5 of gestation, in the labyrinthine cells of the mice placenta and suggest its participation in the formation of the labyrinthine syncytial layers.

Leung Sze Han Candy. / "Architecture Department, Chinese University of Hong Kong, Master of Architecture Programme 2000-2001, design report." / Includes bibliographical references. / Prologue --- p.01 / the Boundaries --- p.03 / Autism a Sensation Boundary --- p.11 / Autism in Hong Kong --- p.15 / Beyond Boundary --- p.23 / The realm of Social Sustainability --- p.25 / Inception of the Children Centre --- p.31 / Site Selection --- p.52 / Selection Criteria --- p.53 / Site Analysis: Kowloon Park --- p.59 / Design Process --- p.65 / Design Principles --- p.67 / Design Development --- p.71 / Final Design --- p.87 / Special Study --- p.93 / Appendix / Interviews / Precedent Study / Feedback from reviewers / Bibliography

Atopic Dermatitis (AD) is a common chronic relapsing inflammatory skin disease affecting 15 - 20% of children and 2 - 10% of adults worldwide, with significant morbidity. A hallmark of AD is disruption of the critical barrier function of upper epidermal layers, causatively linked to environmental stimuli, genetics and infections. Another typical feature of AD is skin infections, especially from Staphylococcus aureus (S. aureus), which closely relates with the disease severity. Although not a normal flora, S. aureus is found on 75-100% of AD lesions (< 30% on healthy skin). S. aureus secrete a range of virulence factors, including extracellular toxins and proteases which contribute to disease pathogenesis. S. aureus serine protease A (SspA/V8) is a well-characterised extracellular protease widely expressed among different S. aureus strains. The pathogenic effect of V8 protease has been demonstrated in vivo, damaging murine skin integrity via effects on the stratum corneum (SC), but the targets for this V8-mediated damage remains unclear. The capacity of proteases to induce barrier dysfunction has been proposed as a key driving force in the initiation and exacerbation of AD. Thus, understanding the host factors that maintain barrier function is a priority in developing novel therapeutic approaches. This thesis therefore aimed at detecting host factors which can combat the barrier dysfunction caused by pathogenic proteases, assessing their relevance in vitro and ex vivo and elucidating the underlying mechanisms. Firstly, an in vitro skin barrier integrity model was developed, using both immortalized and primary keratinocytes, to evaluate the barrier damage mediated by pathogenic proteases. The results revealed that S. aureus protease SspA/V8 is the dominant secreted factor (in laboratory and AD clinical strains of S. aureus) inducing barrier integrity impairment. In addition, studies demonstrated that V8 protease itself was sufficient to induce barrier disruption, and this phenotype was not dependent on cell death, but rather on breaking down of cell-cell junctions. Key tight junction proteins including claudin-1 and occludin were found to be degraded by V8 protease. Next, a wide range of host and bacterial factors were investigated to determine whether they could promote protection of keratinocytes against V8 damage. Several factors, including IL-1β, TNF-α, heat-killed Staphylococcus epidermidis (which is the main skin normal flora), were found to induce protection against V8 protease, with IL-1β having the strongest effect. In addition, data indicated that this IL-1β-mediated protection was independent of effects on claudin-1 but occurred via secretion of a transferrable host factor. Induction of keratinocyte expression of the antimicrobial/host defence peptide human beta-defensin 2 (hBD2) was found to be the mechanism underpinning this IL-1β- induced protective effect. Endogenous hBD2 expression was required and sufficient for protection against V8 protease-mediated integrity damage, and exogenous application of hBD2 was also protective. An ex vivo model using human skin tissue was also established to address this novel function of hBD2, and preliminary data indicated that exogenous hBD2 protected against V8-mediated damage in this system. Overall, my data reveal a novel function for the antimicrobial/host defence peptide hBD2. This modulatory property of hBD2, independent of its antibacterial effects, gives new significance to the defective induction of hBD2 in the barrier-defective skin lesions of AD and indicates therapeutic potential to prevent S. aureus-mediated aggravation of skin barrier dysfunction in AD.

Typescript (photocopy). / Digitized by Kansas Correctional Industries

"The objective of this thesis is to examine the methods of barrier analysis used in the Building Fire Safety Engineering Method (BFSEM), and to develop the areas of the analysis which currently rely almost exclusively on subjective judgment rather than quantitative measures. The use of the Normalized Heat Load to quantify heat energy impact on a barrier is examined in detail. Procedures are developed which apply the properties of a normal statistical distribution to barrier failures times, for use in simplifying the construction of barrier catalog curves. A framework is also developed to help standardize the selection of barrier effectiveness factors. Finally, this thesis outlines the procedure for developing barrier performance curves to allow easy implementation of the barrier analysis into the general framework of the BFSEM. A design example is presented to illustrate the analysis procedures."

Thermal barrier coatings (TBCs) of ZrO2-7wt% Y2O3 were deposited by electron beam physical vapor deposition (EB-PVD) onto stationary flat plates and cylindrical surfaces in a multiple ingot coater. Crystallographic texture, microstructure, and deposition rate were investigated in this thesis. The crystallographic texture of EB-PVD TBCs deposited on stationary flat surfaces has been experimentally determined by comparing pole figure analysis data with actual column growth angle data. It was found that the TBC coating deposited directly above an ingot exhibits <220> single crystal type crystallographic texture. Coatings deposited between and off the centerline of the ingots the exhibited a <311>-type single crystal texture. For coatings deposited in the far corners of the coating chamber either a <111> fiber texture or a <311> single crystal type texture existed. The crystallographic texture of EB-PVD TBCs deposited on cylindrical surfaces was characterized using x-ray diffraction (XRD) at different angular positions on the cylinder substrate. XRD results revealed that crystallographic texture changes with angular position. Changes in crystallographic texture are attributed to the growth direction of the columns and substrate temperature. Growth direction is controlled by the direction of the incoming vapor flux (i.e. vapor incidence angle), in which competition occurs between crystallites growing at different rates. The fastest growing orientation takes over and dominates the texture. Substrate temperature variations throughout the coating chamber resulted in different growth rates and morphology. Morphology differences existed between cylindrical and flat plate surfaces. Flat cross sectional surfaces of the coatings exhibited a dense columnar structure in which the columns grew towards the closest vapor source. Surface features were found to be larger for coatings deposited directly above an ingot than coatings deposited away from the ingots. Morphological differences result from substrate temperature changes within the coating chamber, which influences growth kinetics of the coating. Cylindrical surfaces revealed a columnar structure in which columns grew towards the closest vapor. Porosity of the coating was found to increase when the angular position changed from the bottom of the cylinder. Change in angular position also caused the column diameter to decreases. Morphology changes are attributed to self-shadow effects caused by the surface curvature of the cylinder and vapor incidence angle changes. Overall, the microstructure and crystallographic texture of EB-PVD coatings was found to depend on the position in the coating chamber which was found to influence substrate temperature, growth directions, and shadowing effects. The coating thickness profiles for EB-PVD TBCs deposited on stationary cylinders have been experimentally measured and theoretically modeled using Knudsen's cosine law of emissions. A comparison of the experimental results with the model reveals that the model must to be modified to account for the sticking coefficient as well as a ricochet factor. These results are also discussed in terms of the effects of substrate temperature on the sticking coefficient, the ricochet factor, and coating density.